Overview

Clinical Trial of the Safety and Efficacy of SP160412 in the Temporary Relief of Mild to Moderate Sunburn

Status:
Terminated
Trial end date:
2019-09-25
Target enrollment:
Participant gender:
Summary
A phase II multicenter, double-blinded clinical trial of the safety and efficacy of SP160412 in the temporary relief of mild to moderate, (i.e. first degree) sunburn
Phase:
Phase 2
Details
Lead Sponsor:
Sephoris Pharmaceuticals LLC
Treatments:
Chlorpheniramine
Ibuprofen
Maleic acid